Enterprise Value
60.5M
Cash
10.82M
Avg Qtr Burn
-12.22M
Short % of Float
12.36%
Insider Ownership
0.96%
Institutional Own.
77.13%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
BT-600 Details Inflammatory bowel disease, Ulcerative colitis | Phase 1b Initiation |